(ADPnews) - May 13, 2010 - It is too early for Danish enzyme maker Danisco A/S (CPH:DCO) to take a stance on the new patent law suit filed against it by local rival Novozymes A/S (CPH:NZYM B), Danisco's CEO Tom Knutzen told yesterday Danish newswire RB-Borsen.